OTCBB:PMCB

Pharmacyt Biotch Stock Insider Trading

etoro logo Buy PMCB
*Your capital is at risk
$0.727
-0.0246 (-3.27%)
At Close: Jun 03, 2026

Pharmacyt Biotch Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 73.78. In total, the insiders bought 5.2M and sold 393.75K PMCB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
73.78
Buy 5.2M shares
Sell 393.75K shares
95% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Dec 28, 2022
Buy
Stock Option (Right to Buy)
A-Award
Farb Daniel Stuart
Director
Director 125 000
Value: $0
Dec 28, 2022
Buy
Stock Option (Right to Buy)
A-Award
Allen Daniel
Director
Director 125 000
Value: $0
Nov 14, 2022
Buy
Common Stock
J-Other
Weinstein Robert
Insider
Unknown 0
Value: $0
Nov 14, 2022
Buy
Common Stock
J-Other
Weinstein Robert
Director 0
Value: $0
Nov 14, 2022
Buy
Common Stock
J-Other
Weinstein Robert
Insider
Unknown 0
Value: $0
Nov 14, 2022
Buy
Common Stock
J-Other
Weinstein Robert
Director 0
Value: $0
Aug 15, 2022
Buy
Common Shares
Allen Daniel
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Common Shares
Allen Daniel
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Common Stock
Schechter Jonathan
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Common Stock
J-Other
Stover Jack E
Director 0
Value: $0
Aug 15, 2022
Buy
Common Stock
Silverman Joshua
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Common Stock
Farb Daniel Stuart
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Stock Option (short put)
Farb Daniel Stuart
Director
Director 795 000
Value: $1.99M
Aug 15, 2022
Buy
Common Stock
Schechter Jonathan
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Common Stock
J-Other
Stover Jack E
Director 0
Value: $0
Aug 15, 2022
Buy
Common Stock
Silverman Joshua
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Common Stock
Farb Daniel Stuart
Director
Director 0
Value: $0
Aug 15, 2022
Buy
Stock Option (short put)
Farb Daniel Stuart
Director
Director 795 000
Value: $1.99M
Mar 31, 2022
Buy
Common Stock
Loehr Matthias
Director
Director 0
Value: $0
Mar 31, 2022
Buy
Common Stock
Loehr Matthias
Director
Director 0
Value: $0
Aug 10, 2021
Buy
Common Stock
Trujillo Carlos
CFO
C-Suite Officer 0
Value: $0
Aug 10, 2021
Buy
Common Stock
Trujillo Carlos
CFO
C-Suite Officer 0
Value: $0
Aug 10, 2021
Buy
Common Stock
Waggoner Kenneth L.
Chairman, CEO, Pres And GC
CEO / President 0
Value: $0
Aug 10, 2021
Buy
Common Stock
Yuen Thomas C K
Director
Director 0
Value: $0
Aug 10, 2021
Buy
Common Stock
Crabtree Gerald W
Chief Science Officer
Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PHARMACYT BIOTCH
Pharmacyt Biotch
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE